Home
Conditions
Leukemia, Prolymphocytic, B-Cell

Clinical trial condition

Leukemia, Prolymphocytic, B-Cell

Explore clinical trials studying Leukemia, Prolymphocytic, B-Cell. Study availability and eligibility vary by location and protocol.

11 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Prolymphocytic, B-Cell trial results

Recruiting

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

NCT05418088

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +44 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Registry of the German CLL Study Group

NCT02863692

Conditions: CLL, HCL, Hematologic Diseases, +19 more
Locations: BAG Freiberg-Richter, Jacobasch, Wolf, Illmer Dresden, Saxony, Germany

View Trial Details

Completed

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

NCT04312841

Conditions: B-Cell Prolymphocytic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +28 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

NCT02924402

Conditions: B-Cell Non-Hodgkins Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations: Moores UC San Diego Cancer Center La Jolla, California, United States

Mayo Clinic Jacksonville, Florida, United States

Northside Hospital Atlanta, Georgia, United States

The University of Chicago Medicine Chicago, Illinois, United States

View all 23 locations

View Trial Details

Completed

Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

NCT03010358

Conditions: Anemia, B-Cell Prolymphocytic Leukemia, Chronic Disease, +36 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01886859

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +21 more
Locations: Stanford Cancer Institute Palo Alto Palo Alto, California, United States

University of Colorado Hospital Aurora, Colorado, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies

NCT01094860

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +39 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

NCT01008462

Conditions: B-Cell Prolymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +51 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia

NCT00060424

Conditions: B-Cell Prolymphocytic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +24 more
Locations: Veterans Administration Center-Seattle Seattle, Washington, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

University of Torino Torino, Italy

View Trial Details

Active, Not Recruiting

Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma

NCT03479268

Conditions: B-Cell Prolymphocytic Leukemia, Chronic Disease, Disease Attributes, +40 more
Locations: City of Hope Medical Center Duarte, California, United States

Roswell Park Comprehensive Cancer Center Buffalo, New York, United States

View Trial Details

Leukemia, Prolymphocytic, B-Cell

Leukemia, Prolymphocytic, B-Cell trial results

Related conditions